U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396220) titled 'Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation' on Feb. 01.
Brief Summary: The purpose of this study is to examine the effects of combined intranasal esketamine with brief cognitive behavioral therapy for suicide prevention (BCBT-SP) for suicidal ideation (SI) in patients with treatment- resistant depression (TRD). The secondary aim is to identify the biological targets of treatment response using combined transcranial magnetic stimulation and electroencephalography (TMS-EEG). In this project we will recruit patients between the ages of 18 and 70, diagnosed with a major depressive episode wi...